The stock of Bluebird bio Inc (NASDAQ:BLUE) last traded at $0.61, up 5.54% from the previous session.
BLUE stock price is now -32.94% away from the 50-day moving average and -53.37% away from the 200-day moving average. The market capitalization of the company currently stands at $116.76M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
, while ‘Morgan Stanley’ rates the stock as ‘Equal-Weight’
In other news, Klima Thomas J, insider sold 3,834 shares of the company’s stock on Jun 03 ’24. The stock was sold for $3,726 at an average price of $0.97. Upon completion of the transaction, the insider now directly owns 121,006 shares in the company, valued at $73813.66. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 01 ’24, Chief Medical Officer Colvin Richard A sold 6,770 shares of the business’s stock. A total of $10,342 was realized by selling the stock at an average price of $1.53. This leaves the insider owning 118,368 shares of the company worth $72204.48. A total of 0.62% of the company’s stock is owned by insiders.
During the past 12 months, Bluebird bio Inc has had a low of $0.52 and a high of $5.53. As of last week, the company has a debt-to-equity ratio of 3.16, a current ratio of 0.93, and a quick ratio of 0.82. The fifty day moving average price for BLUE is $0.8972 and a two-hundred day moving average price translates $1.28295 for the stock.
The latest earnings results from Bluebird bio Inc (NASDAQ: BLUE) was released for 2024-03-31. The net profit margin was -646.25% and return on equity was -121.56% for BLUE. The company reported revenue of $12.39 million for the quarter, compared to $71000.0 a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 17353.52 percent.
